These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 19318114

  • 1. A new class of inhibitors of peptide sorption and acylation in PLGA.
    Sophocleous AM, Zhang Y, Schwendeman SP.
    J Control Release; 2009 Aug 04; 137(3):179-84. PubMed ID: 19318114
    [Abstract] [Full Text] [Related]

  • 2. Minimizing acylation of peptides in PLGA microspheres.
    Zhang Y, Schwendeman SP.
    J Control Release; 2012 Aug 20; 162(1):119-26. PubMed ID: 22546683
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of peptide acylation in PLGA microspheres with water-soluble divalent cationic salts.
    Zhang Y, Sophocleous AM, Schwendeman SP.
    Pharm Res; 2009 Aug 20; 26(8):1986-94. PubMed ID: 19533307
    [Abstract] [Full Text] [Related]

  • 4. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
    Ghassemi AH, van Steenbergen MJ, Barendregt A, Talsma H, Kok RJ, van Nostrum CF, Crommelin DJ, Hennink WE.
    Pharm Res; 2012 Jan 20; 29(1):110-20. PubMed ID: 21744173
    [Abstract] [Full Text] [Related]

  • 5. The nature of peptide interactions with acid end-group PLGAs and facile aqueous-based microencapsulation of therapeutic peptides.
    Sophocleous AM, Desai KG, Mazzara JM, Tong L, Cheng JX, Olsen KF, Schwendeman SP.
    J Control Release; 2013 Dec 28; 172(3):662-70. PubMed ID: 24021356
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of Octreotide Acylation Inside PLGA Microspheres by Derivatization of the Amines of the Peptide with a Self-Immolative Protecting Group.
    Shirangi M, Najafi M, Rijkers DT, Kok RJ, Hennink WE, van Nostrum CF.
    Bioconjug Chem; 2016 Mar 16; 27(3):576-85. PubMed ID: 26726953
    [Abstract] [Full Text] [Related]

  • 7. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.
    Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Qin B, Schwendeman SP.
    Mol Pharm; 2020 Nov 02; 17(11):4141-4151. PubMed ID: 32876463
    [Abstract] [Full Text] [Related]

  • 8. Proton Oriented-"Smart Depot" for Responsive Release of Ca2+ to Inhibit Peptide Acylation in PLGA Microspheres.
    Liu J, Xu Y, Wang Y, Ren H, Meng Z, Liu K, Liu Z, Huang H, Li X.
    Pharm Res; 2019 Jun 04; 36(8):119. PubMed ID: 31165279
    [Abstract] [Full Text] [Related]

  • 9. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release.
    Liang D, Frank S, Schwendeman SP.
    Drug Deliv Transl Res; 2024 Mar 04; 14(3):696-704. PubMed ID: 38038895
    [Abstract] [Full Text] [Related]

  • 10. Microcosmic mechanism of dication for inhibiting acylation of acidic Peptide.
    Qi F, Yang L, Wu J, Ma G, Su Z.
    Pharm Res; 2015 Jul 04; 32(7):2310-7. PubMed ID: 25585955
    [Abstract] [Full Text] [Related]

  • 11. Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method.
    Beig A, Ackermann R, Wang Y, Schutzman R, Schwendeman SP.
    Int J Pharm; 2022 Aug 25; 624():121842. PubMed ID: 35609832
    [Abstract] [Full Text] [Related]

  • 12. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).
    Na DH, DeLuca PP.
    Pharm Res; 2005 May 25; 22(5):736-42. PubMed ID: 15906168
    [Abstract] [Full Text] [Related]

  • 13. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG, Mallery SR, Schwendeman SP.
    Pharm Res; 2008 Mar 25; 25(3):586-97. PubMed ID: 17891553
    [Abstract] [Full Text] [Related]

  • 14. Characterization of Octreotide-PLGA Binding by Isothermal Titration Calorimetry.
    Hong JKY, Schwendeman SP.
    Biomacromolecules; 2020 Oct 12; 21(10):4087-4093. PubMed ID: 32885949
    [Abstract] [Full Text] [Related]

  • 15. Reversible hydrophobic ion-paring complex strategy to minimize acylation of octreotide during long-term delivery from PLGA microparticles.
    Vaishya RD, Mandal A, Gokulgandhi M, Patel S, Mitra AK.
    Int J Pharm; 2015 Jul 15; 489(1-2):237-45. PubMed ID: 25940041
    [Abstract] [Full Text] [Related]

  • 16. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
    Murty SB, Goodman J, Thanoo BC, DeLuca PP.
    AAPS PharmSciTech; 2003 Oct 13; 4(4):E50. PubMed ID: 15198545
    [Abstract] [Full Text] [Related]

  • 17. Extended release microparticle-in-gel formulation of octreotide: Effect of polymer type on acylation of peptide during in vitro release.
    Vaishya RD, Mandal A, Patel S, Mitra AK.
    Int J Pharm; 2015 Dec 30; 496(2):676-88. PubMed ID: 26561725
    [Abstract] [Full Text] [Related]

  • 18. Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry.
    Na DH, Youn YS, Lee SD, Son MW, Kim WB, DeLuca PP, Lee KC.
    J Control Release; 2003 Oct 30; 92(3):291-9. PubMed ID: 14568410
    [Abstract] [Full Text] [Related]

  • 19. Identification and Assessment of Octreotide Acylation in Polyester Microspheres by LC-MS/MS.
    Shirangi M, Hennink WE, Somsen GW, van Nostrum CF.
    Pharm Res; 2015 Sep 30; 32(9):3044-54. PubMed ID: 25832500
    [Abstract] [Full Text] [Related]

  • 20. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles.
    Samadi N, Abbadessa A, Di Stefano A, van Nostrum CF, Vermonden T, Rahimian S, Teunissen EA, van Steenbergen MJ, Amidi M, Hennink WE.
    J Control Release; 2013 Dec 10; 172(2):436-43. PubMed ID: 23751568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.